BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/4/2017 8:44:34 AM | Browse: 883 | Download: 1535
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 30029
Country/Territory Italy
Received
2016-09-05 11:07
Peer-Review Started
2016-09-05 14:12
To Make the First Decision
2016-10-20 08:31
Return for Revision
2016-11-02 16:46
Revised
2016-12-05 02:02
Second Decision
2017-01-13 17:45
Accepted by Journal Editor-in-Chief
2017-01-14 00:37
Accepted by Company Editor-in-Chief
2017-01-18 10:28
Articles in Press
2017-01-18 10:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-04-28 10:06
Publish the Manuscript Online
2017-05-04 08:16
ISSN 2150-5349 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study
Manuscript Source Invited Manuscript
All Author List Anna Viola, Giuseppe Costantino, Antonino Carlo Privitera, Fabrizio Bossa, Angelo Lauria, Laurino Grossi, Maria Beatrice Principi, Nicola Della Valle and Maria Cappello
Funding Agency and Grant Number
Corresponding Author Maria Cappello, MD, Gastroenterology and Hepatology Section, Dipartimento Biomedico di Medicina Interna e Specialistica, University of Palermo, Piazza Delle Cliniche 2, 90127 Palermo, Italy. marica.cappello61@gmail.com
Key Words Infliximab; One-hour infusion; Cost savings; Economic impact; Multicenter study
Core Tip Infliximab (IFX) is a monoclonal antibody anti-tumour necrosis factor used in the treatment of moderate-to-severe inflammatory bowel diseases refractory to conventional therapy. It is usually administered i.v. at a dose of 5 mg/kg as a 2-h infusion. Shortening the infusion protocol to 1 h is equally safe and positively affects quality of life. This paper analyzes the impact of short IFX infusion on hospital resource utilization and costs, both in terms of time saving and increased infusion unit capacity. In addition, we provide evidence of indirect patient-related cost savings.
Publish Date 2017-05-04 08:16
Citation Viola A, Costantino G, Privitera AC, Bossa F, Lauria A, Grossi L, Principi MB, Della Valle N, Cappello M. Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study. World J Gastrointest Pharmacol Ther 2017; 8(2): 131-136
URL http://www.wjgnet.com/2150-5349/full/v8/i2/131.htm
DOI http://dx.doi.org/10.4292/wjgpt.v8.i2.131
Full Article (PDF) WJGPT-8-131.pdf
Full Article (Word) WJGPT-8-131.doc
Manuscript File 30029-Review.docx
Answering Reviewers 30029-Answering reviewers.pdf
Audio Core Tip 30029-Audio core tip.wma
Conflict-of-Interest Disclosure Form 30029-Conflict-of-interest statement.pdf
Copyright License Agreement 30029-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s) Informed_Consent_Statement_20160905041941.docx
Institutional Review Board Approval Form or Document 30029-Institutional review board statement.pdf
Peer-review Report 30029-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 30029-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 30029-Scientific misconduct check.pdf
Scientific Editor Work List 30029-Scientific editor work list.pdf